2024 / 06

DOI: 10.24075/brsmu.2024.074
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Prospects of gene therapy with hematopoietic stem cells

Valieva YM1, Popov KV2
About authors

1 Moscow Institute of Physics and Technology (National Research University), Moscow, Russia

2 Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Konstantin V. Popov
Akademika Oparina, 4, Moscow, 117997, Russia; ur.liam@tsnok_vopop

About paper

Funding: the paper was executed within the framework of the State Assignment of the Ministry of Health of the Russian Federation No. 123020800103-6.

Author contribution: Valieva YM — literature review, data acquisition, manuscript writing; Popov KV — manuscript concept, editing.

Received: 2024-12-25 Accepted: 2024-12-29 Published online: 2024-12-31
|
  1. Carvalho M, Sepodes B, Martins AP. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework. Frontiers in Medicine [Internet]. 2017; 4. Available from: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2017.00182/full.
  2. Wang D, Gao G. State-of-the-art human gene therapy: part ii. gene therapy strategies and applications. 2014. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4440458/.
  3. CAR T Cells: Engineering Immune Cells to Treat Cancer [Internet]. Cancer gov. 2022. Available from: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells.
  4. Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduction and Targeted Therapy. 2024; 9 (1). Available from: https://pubmed.ncbi.nlm.nih.gov/38565561/.
  5. Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, et al. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency. New England Journal of Medicine. 2021; 384 (21): 2002–13. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2027675.
  6. Zhu Y, Zhu L, Wang X, Jin H. RNA-based therapeutics: an overview and prospectus. Cell Death and Disease [Internet]. 2022 Jul 23;13(7). Available from: https://www.nature.com/articles/s41419-022-05075-2
  7. Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, et al. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduction and Targeted Therapy. 2023; 8 (1). Available from: https://www.nature.com/articles/s41392-023-01309-7.
  8. Ferrari S, Valeri E, Conti A, Scala S, Aprile A, Di Micco R, et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell]. 2023; 30 (5): 549– 70. Available from: https://pubmed.ncbi.nlm.nih.gov/37146580/.
  9. Meaker GA, Wilkinson AC. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions. Experimental Hematology]. 2023; 130: 104136. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11511678/.
  10. Horgan C, Watts K, Ram D, Rust S, Hutton R, Jones S, et al. A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead. JIMD Reports. 2023; 64 (5): 346–52. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmd2.12378.
  11. Duncan CN, Bledsoe JR, Grzywacz B, Beckman A, Bonner M, Eichler FS, et al. Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine. 2024; 391 (14): 1287–301. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2405541.
  12. Rabinowitz J, Chan YK, Samulski RJ. Adeno-Associated Virus (AAV) Versus Immune Response. Viruses. 2019; 11 (2): 102. Available from: https://www.mdpi.com/1999-4915/11/2/102.
  13. de Vasconcelos P, Lacerda JF. Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism. Front Cell Neurosci. 2022; 16: 895511. Available from: https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.895511/full.
  14. Mikulska M, Gualandi F, Anserini P. Early and late complications of hematopoietic stem cell transplantation. Handb Clin Neurol. 2024; 202: 135–51.
  15. Maragkou I, Maragkou I. The most expensive drugs in the US. Pharmaceutical Technology. 2024. Available from: https://www.pharmaceutical-technology.com/features/the-most-expensive-drugs-in-the-us/.